+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars And Biosuperiors Market Research Reports

From
From
From
From
From
Biobetters Market Report, Global, 2024 - Product Thumbnail Image

Biobetters Market Report, Global, 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Biosimilars - Global Strategic Business Report - Product Thumbnail Image

Biosimilars - Global Strategic Business Report

  • Report
  • March 2025
  • 193 Pages
  • Global
From
Biologic & Biosimilar RA Drugs Market Report 2025 - Product Thumbnail Image

Biologic & Biosimilar RA Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Biosimilar Market Report 2025-2033 - Product Thumbnail Image

Biosimilar Market Report 2025-2033

  • Report
  • January 2025
  • 123 Pages
  • Global
From
From
Etanercept - Biosimilar Insight, 2024 - Product Thumbnail Image

Etanercept - Biosimilar Insight, 2024

  • Report
  • August 2024
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

The Biosimilars and Biosuperiors market is a rapidly growing sector of the pharmaceutical industry. Biosimilars are biologic drugs that are highly similar to an existing biologic drug, while biosuperiors are biologic drugs that are more effective than an existing biologic drug. Biosimilars and biosuperiors are used to treat a variety of conditions, including cancer, autoimmune diseases, and inflammatory diseases. Biosimilars and biosuperiors are developed using advanced biotechnology techniques, such as recombinant DNA technology and monoclonal antibody technology. These drugs are designed to be more cost-effective than their original counterparts, while still providing the same therapeutic benefits. The Biosimilars and Biosuperiors market is expected to continue to grow in the coming years, as more biologic drugs are developed and approved for use. Companies in this market include Amgen, Pfizer, Merck, and Novartis. Show Less Read more